Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Efficacy of Enzyme Replacement Therapy in Fabry Disease
pp. 277-286(10)
Authors: F. Barbey; D. Hayoz; U. Widmer; M. Burnier

Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure
pp. 287-294(8)
Authors: D. Fraccarollo; P. Galuppo; J. Bauersachs

Emerging Technologies in Biocompatible Surface Modifying Additives: Quest for Physiologic Cardiopulmonary Bypass
pp. 295-302(8)
Author: Serdar Gunaydin

2-Antiplasmin: Potential Therapeutic Roles in Fibrin Survival and Removal
pp. 303-310(8)
Authors: Kyung N. Lee; Kenneth W. Jackson; Victoria J. Christiansen; Keun H. Chung; Patrick A. McKee

Novel Antithrombotic Agents: Indirect Synthetic Inhibitors of Factor Xa and Direct Thrombin Inhibitors. Evidences from Clinical Studies
pp. 311-326(16)
Authors: Giuseppe Leone; Elena Rossi; Antonio M. Leone; Valerio D.e. Stefano

Atherosclerosis - New Targets and Therapeutics
pp. 327-334(8)
Authors: Sivaram Pillarisetti; Christopher W. Alexander; Uday Saxena

Urocortins: Take Them to Heart
pp. 335-342(8)
Authors: Tiziano Scarabelli; Richard Knight

Salutary Properties of YC-1 in the Cardiovascular and Hematological Systems
pp. 343-359(17)
Author: David A. Tulis